Group One Trading
RPRX icon

Group One Trading’s Royalty Pharma RPRX Stock Holding History

Group One Trading’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Buy
23,100
+1,400
+6% +$61.3K ﹤0.01% 2610
2025
Q4 		$838K Buy
21,700
+14,800
+214% +$564K ﹤0.01% 3062
2025
Q3 		$243K Sell
6,900
-35,800
-84% -$1.3M ﹤0.01% 4466
2025
Q2 		$1.54M Sell
42,700
-92,400
-68% -$3.06M ﹤0.01% 2376
2025
Q1 		$4.21M Buy
+135,100
New +$4.28M 0.01% 1210
2024
Q2 		– Sell
-10,000
Closed -$304K – 7377
2024
Q1 		$304K Sell
10,000
-30,000
-75% -$884K ﹤0.01% 3204
2023
Q4 		$1.12M Buy
40,000
+9,900
+33% +$272K ﹤0.01% 2365
2023
Q3 		$817K Buy
30,100
+19,500
+184% +$579K ﹤0.01% 2465
2023
Q2 		$326K Buy
10,600
+10,400
+5,200% +$352K ﹤0.01% 3462
2023
Q1 		$7.21K Buy
+200
New +$7.42K ﹤0.01% 6123
2022
Q2 		– Sell
-1,300
Closed -$51K – 8428
2022
Q1 		$51K Sell
1,300
-500
-28% -$19.6K ﹤0.01% 6084
2021
Q4 		$72K Sell
1,800
-2,700
-60% -$105K ﹤0.01% 6031
2021
Q3 		$163K Buy
4,500
+1,400
+45% +$54.4K ﹤0.01% 5377
2021
Q2 		$127K Buy
3,100
+1,000
+48% +$42.5K ﹤0.01% 5724
2021
Q1 		$92K Buy
2,100
+1,700
+425% +$80.6K ﹤0.01% 5733
2020
Q4 		$20K Sell
400
-500
-56% -$21.2K ﹤0.01% 5524
2020
Q3 		$38K Buy
+900
New +$38.6K ﹤0.01% 4814

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Group One Trading's RPRX Position: Q1 2026 in Review

Group One Trading sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 10,093 shares — an estimated $442K sold.

Group One Trading first reported a position in RPRX in Q1 2021 and held it in 3 quarters. The position peaked at $390K in Q4 2025. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Group One Trading reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 10,093 Royalty Pharma shares in Q1 2026, an estimated $442K.
  • Group One Trading first reported a position in Royalty Pharma in Q1 2021 and held it in 3 quarters.
  • Group One Trading's Royalty Pharma position peaked at $390K in Q4 2025.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.